| Literature DB >> 36243879 |
Cristina Del Seppia1, Giuseppe Federighi2, Dosminga Lapi3, Federico Gerosolimo2, Rossana Scuri2.
Abstract
Hypertension represents the main risk factor for the onset of cardiovascular diseases. Pharmacological treatments to control hypertension have been associated with new treatments involving physical activity and/or the intake of natural components (nutraceuticals). We here report the effects produced by a combination of a natural component (catechins) and a moderate exercise program on the development of hypertension in spontaneous hypertensive rats compared with those of each individual treatment. Arterial blood pressure and heart rate were measured with a non-invasive method in 28 rats randomly assigned to four groups: rats subjected to moderate physical exercise; rats with a catechins-enriched diet; rats subjected to moderate physical exercise combined with a catechins-enriched diet; control, untreated-rats left to age. All treatments were applied for 6 weeks. The statistical analysis revealed that the three treatments significantly reduced the weekly increase in arterial blood pressure observed in control rats (SBP, P < 0.0001; DBP, P = 0.005). However, the reduction of arterial blood pressure induced by combined treatments was not higher than that induced by the single treatment, but more prolonged. All treatments showed strong antioxidative properties. Our data show that physical activity and a diet enriched with catechins individually have an important hypotensive effect, while the association did not produce a higher hypotensive effect than the single treatment, even if it was able to decrease blood pressure for a longer time. These findings have important implications for developing a protocol to apply in novel hypertension prevention procedures.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36243879 PMCID: PMC9569358 DOI: 10.1038/s41598-022-21458-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Parameters measured in the four groups at the arrival in our lab and at the end of the treatments (Means ± S.E.)
| Basal | At the end of the treatment | |||||||
|---|---|---|---|---|---|---|---|---|
| Weight (g) | SBP (mmHg) | DBP (mmHg) | HR (bites/min) | Weight (g) | SBP (mmHg) | DBP (mmHg) | HR (bites/min) | |
| Control | 95 ± 1.00 | 108 ± 1.12 | 81 ± 3.23 | 545 ± 4.95 | 280 ± 8.26 | 226 ± 1.96 | 197 ± 4.41 | 618 ± 29.76 |
| Training | 100 ± 1.05 | 109 ± 0.20 | 88 ± 2.85 | 536 ± 7.89 | 263 ± 7.63 | 173 ± 1.15 | 153 ± 4.46 | 587 ± 14.18 |
| Catechins | 93 ± 2.30 | 110 ± 2.50 | 82 ± 4.76 | 546 ± 11.28 | 275 ± 6.19 | 168 ± 2.24 | 150 ± 2.33 | 514 ± 9.92 |
| Training + catechins | 97 ± 1.87 | 108 ± 1.50 | 83 ± 1.01 | 543 ± 2.89 | 272 ± 3.31 | 189 ± 2.47 | 173 ± 4.31 | 537 ± 28.73 |
Training session planning.
| Week of training | Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
|---|---|---|---|---|---|---|---|
| 1 | 5 m/min × 4 min 6 m/min × 6 min 7 m/min × 10 min | Rest | 5–7 m/min × 6 min 8 m/min × 4 min 9 m/min × 5 min 10 m /min × 5 min 11 m/min × 5 min | Rest | 5–11 m/min × 5 min 11 m/min × 15 min 9 m/min × 5 11 m/min × 5 min | Rest and blood pressure measurement | Rest |
| 2 | 7–9 m/min × 3 min 10–12 m/min × 2 min 12 m/min × 5 min 13 m/min × 10 min 12 m/min × 10 min | Rest | 7–9 m/min × 3 min 10–12 m/min × 2 min 12 m/min × 5 min 13 m/min × 10 min 12 m/min × 10 min | Rest | 7–9 m/min × 3 min 10–12 m/min × 2 min 12 m/min × 5 min 13 m/min × 10 min 12 m/min × 10 min | Rest and blood pressure measurement | Rest |
| 3 | 7–9 m/min × 2 min 10–13 m/min × 3 min 13 m/min × 5 min 14 m/min × 10 min 13 m/min × 10 min | Rest | 7–9 m/min × 2 min 10–13 m/min × 3 min 13 m/min × 5 min 14 m/min × 10 min 13 m/min × 10 min | Rest | 7–9 m/min × 2 min 10–13 m/min × 3 min 13 m/min × 5 min 14 m/min × 10 min 13 m/min × 10 min | Rest and blood pressure measurement | Rest |
| 4 | 7–9 m/min × 2 min 10–14 m/min × 3 min 14 m/min × 5 min 15 m/min × 10 min 14 m/min × 10 min | Rest | 7–9 m/min × 2 min 10–14 m/min × 3 min 14 m/min × 5 min 15 m/min × 10 min 14 m/min × 10 min | Rest | 7–9 m/min × 2 min 10–14 m/min × 3 min 14 m/min × 5 min 15 m/min × 10 min 14 m/min × 10 min | Rest and blood pressure measurement | Rest |
| 5 | 8–10 m/min × 2 min 11–15 m/min × 3 min 15 m/min × 5 min 16 m/min × 10 min 15 m/min × 10 min | Rest | 8–10 m/min × 2 min 11–15 m/min × 3 min 15 m/min × 5 min 16 m/min × 10 min 15 m/min × 10 min | Rest | 8–10 m/min × 2 min 11–15 m/min × 3 min 15 m/min × 5 min 16 m/min × 10 min 15 m/min × 10 min | Rest and blood pressure measurement | Rest |
| 6 | 9–11 m/min × 2 min 12–16 m/min × 3 min 16 m/min × 5 min 17 m/min × 10 min 16 m/min × 10 min | Rest | 9–11 m/min × 2 min 12–16 m/min × 3 min 16 m/min × 5 min 17 m/min × 10 min 16 m/min × 10 min | Rest | 9–11 m/min × 2 min 12–16 m/min × 3 min 16 m/min × 5 min 17 m/min × 10 min 16 m/min × 10 min | Rest and blood pressure measurement | Rest |
Significant values are in bold.
Figure 1Picture of the training apparatus.
Figure 2Distance travelled by the trained rats (black circles) and the rats subjected to moderate physical exercise associated with the catechins-enriched diet (black squares) during every test session. Asterisks indicate significant differences (P < 0.0001) between the two groups in post hoc comparisons after two-way ANOVA for repeated measures (F17, 72 = 2.096, P = 0.0159).
Figure 3Evaluation of ROS formation in pial microvasculature of the parietal cortex. ROS formation was quantified by NGL (A). Computer-assisted images of pial microvascular networks showing fluorescence spots corresponding to the presence of ROS (B).
Figure 4Time-course of systolic blood pressure (SBP, mean ± SEM) in the different groups of rats considered (A). Summary of the statistical analysis results (B).
Figure 5Time-course of diastolic blood pressure (DBP, mean ± SEM) in the different groups of rats considered (A). Summary of the statistical analysis results (B).
Heart rate measured at the arrival in our lab (basal) and at the different times considered.
| HR (bpm) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basal | 1 week | 2 week | 3 week | 4 week | 5 week | 6 week | 4 days after the end of treatments | |||||||||
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
| Control | 545 | 4.95 | 575 | 11.33 | 641 | 15.88 | 640 | 14.23 | 551 | 7.12 | 545 | 16.31 | 618 | 29.76 | 534 | 34.92 |
| Training | 536 | 7.89 | 614 | 33.48 | 544 | 32.53 | 536 | 34.56 | 586 | 14.81 | 553 | 25.46 | 587 | 14.18 | 555 | 69.33 |
| Catechin | 546 | 11.28 | 569 | 31.88 | 612 | 45.73 | 513 | 58,09 | 508 | 27.61 | 526 | 21.09 | 514 | 29.92 | 568 | 34.49 |
| Training + catechin | 543 | 2.89 | 488 | 44.30 | 565 | 33.28 | 580 | 20.46 | 509 | 9.45 | 596 | 38.4 | 537 | 28.73 | 558 | 20.66 |
SBP mean changes (mmHg) from basal values at the different times considered.
| 1 week | 2 week | 3 week | 4 week | 5 week | 6 week | 4 days after the of treatments | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
| Control | 13.75 | 1.75 | 62.5 | 2.04 | 75.00 | 0.57 | 87.13 | 4.10 | 110.25 | 5.29 | 118.00 | 1.87 | 99.38 | 2.68 |
| Training | 46.50 | 1.40 | 36.2 | 2.52 | 29.89 | 0.38 | 34.56 | 2.94 | 60.30 | 5.26 | 63.80 | 1.16 | 76.72 | 0.85 |
| Catechin | − 0.23 | 0.10 | 1.50 | 3.48 | 22.00 | 1.01 | 41.50 | 1.16 | 43.50 | 1.43 | 58.00 | 2.00 | 80.52 | 0.54 |
| Training + catechin | − 2.30 | 2.03 | 20.02 | 1.56 | 30.27 | 1.08 | 58.40 | 0.51 | 64.80 | 0.34 | 80.90 | 10.86 | 91.80 | 0.86 |
DBP mean changes (mmHg) from basal values at the different times considered.
| 1 week | 2 week | 3 week | 4 week | 5 week | 6 week | 4 days after the of treatments | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
| Control | 15.38 | 2.40 | 72.25 | 1.25 | 74.13 | 0.99 | 94.38 | 5.18 | 113.88 | 3.52 | 116.25 | 4.18 | 105.50 | 3.26 |
| Training | 46.40 | 2.51 | 45.20 | 2.30 | 35.86 | 3.31 | 31.12 | 3.22 | 62.10 | 6.88 | 65.00 | 4.78 | 80.82 | 1.94 |
| Catechin | 3.20 | 1.53 | 13.13 | 2.57 | 31.50 | 0.93 | 69.50 | 1.16 | 51.63 | 1.06 | 67.88 | 2.08 | 91.00 | 2.21 |
| Training + catechin | 3.30 | 2.38 | 26.02 | 3.84 | 32.40 | 1.61 | 61.40 | 1.96 | 70.10 | 1.54 | 90.40 | 4.05 | 92.10 | 1.90 |
Results of statistical analysis on SBP increases.
| Groups | Mean differences | SD | Confidence interval (95%) | |||
|---|---|---|---|---|---|---|
| (I) group | (J) group | Inferior limit | Superior limit | |||
| Control vs | Training | 31.15 | 1.44 | < 0.001 | 26.80 | 35.49 |
| Catechin | 45.60 | 1.44 | < 0.001 | 41.26 | 49.94 | |
| Training + catechin | 31.73 | 1.44 | < 0.001 | 27.3°9 | 36.07 | |
| Training vs | Control | 31.15 | 1.44 | < 0.001 | − 35.49 | − 26.80 |
| Catechin | 14.50 | 1.44 | < 0.001 | 10.11 | 18.79 | |
| Training + catechin | 0.58 | 1.44 | 1.000 | − 3.76 | 4.92 | |
| Catechin vs | Control | − 45.60 | 1.44 | < 0.001 | − 49.94 | − 41.25 |
| Training | − 14.45 | 1.44 | < 0.001 | − 18.79 | − 10.10 | |
| Training + catechin | − 13.87 | 1.44 | < 0.001 | − 18.21 | − 9.53 | |
| Training + catechin vs | Control | − 31.73 | 1.44 | < 0.001 | − 36.07 | − 27.39 |
| Training | − 0.58 | 1.44 | 1.000 | − 4.92 | 3.76 | |
| Catechin | 13.87 | 1.44 | < 0.001 | 9.53 | 18.21 | |
Results of statistical analysis on DBP increases.
| Groups | Mean differences | SD | P | Confidence interval (95%) | ||
|---|---|---|---|---|---|---|
| Inferior limit | Superior limit | |||||
| Control vs | Training | 32.75 | 1.87 | < 0.001 | 27.13 | 38.37 |
| Catechin | 38.28 | 1.87 | < 0.001 | 32.65 | 43.90 | |
| Training + catechin | 31.43 | 1.87 | < 0.001 | 25.80 | 37.06 | |
| Training vs | Control | − 32.75 | 1.87 | < 0.001 | − 358.37 | − 27.13 |
| Catechin | 5.52 | 1.87 | = 0.056 | − 0.01 | 11.15 | |
| Training + catechin | − 1.32 | 1.87 | 1.000 | − 6.94 | 4.31 | |
| Catechin vs | Control | − 38.28 | 1.87 | < 0.001 | − 43.90 | − 32.65 |
| Training | − 5.52 | 1.87 | = 0.056 | − 11.15 | 0.01 | |
| Training + catechin | − 6.847 | 1.87 | = 0.013 | − 12.47 | − 1.22 | |
| Training + catechin vs | Control | − 31.43 | 1.87 | < 0.001 | − 37.06 | − 25.81 |
| Training | 1.32 | 1.87 | 1.000 | − 4.31 | 6.94 | |
| Catechin | 6.84 | 1.87 | = 0.013 | 1.22 | 12.47 | |
Figure 6Time-course of rate pressure product (RPP, mean ± SEM) in the different groups of rats considered (A). Summary of statistical analysis results (B).